Global Codeine Market Research Report 2020

Publisher Name :
Date: 27-Mar-2020
No. of pages: 124
Inquire Before Buying

The global Codeine market is valued at US$ 313 million in 2020 is expected to reach US$ 205.7 million by the end of 2026, growing at a CAGR of -5.5% during 2021-2026.

This report focuses on Codeine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Codeine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Middle East and India etc.

Market Segment Analysis

The research report includes specific segments by Ingredient and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Ingredient, the Codeine market is segmented into

- Single-ingredient Codeine

- Multi-ingredient Medications

Segment by Application

- Narcotic Analgesic

- Antitussive

- Others

Global Codeine Market: Regional Analysis

The Codeine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Ingredient and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Codeine market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Codeine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Codeine market include:

- Taiji

- Mallinckrodt

- TEVA

- Johnson & Johnson

- Medreich

- Sanofi Aventis

- Cipla

- Hikma

- Pharmaceutical Associates

- Novartis

- Apotex

- Mylan

- Aristo Pharma GmbH

- Lannett Company

- Laboratoire Riva

Global Codeine Market Research Report 2020

Table of Contents
1 Codeine Market Overview
1.1 Product Overview and Scope of Codeine
1.2 Codeine Segment by Ingredient
1.2.1 Global Codeine Sales Growth Rate Comparison by Ingredient (2021-2026)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Segment by Application
1.3.1 Codeine Sales Comparison by Application: 2020 VS 2026
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Market Size Estimates and Forecasts
1.4.1 Global Codeine Revenue 2015-2026
1.4.2 Global Codeine Sales 2015-2026
1.4.3 Codeine Market Size by Region: 2020 Versus 2026
2 Global Codeine Market Competition by Manufacturers
2.1 Global Codeine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Codeine Revenue Share by Manufacturers (2015-2020)
2.3 Global Codeine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Codeine Manufacturing Sites, Area Served, Product Type
2.5 Codeine Market Competitive Situation and Trends
2.5.1 Codeine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Codeine Players (Opinion Leaders)
3 Codeine Retrospective Market Scenario by Region
3.1 Global Codeine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Codeine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Codeine Market Facts & Figures by Country
3.3.1 North America Codeine Sales by Country
3.3.2 North America Codeine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Codeine Market Facts & Figures by Country
3.4.1 Europe Codeine Sales by Country
3.4.2 Europe Codeine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Codeine Market Facts & Figures by Region
3.5.1 Asia Pacific Codeine Sales by Region
3.5.2 Asia Pacific Codeine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Codeine Market Facts & Figures by Country
3.6.1 Latin America Codeine Sales by Country
3.6.2 Latin America Codeine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Codeine Market Facts & Figures by Country
3.7.1 Middle East and Africa Codeine Sales by Country
3.7.2 Middle East and Africa Codeine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Codeine Historic Market Analysis by Ingredient
4.1 Global Codeine Sales Market Share by Ingredient (2015-2020)
4.2 Global Codeine Revenue Market Share by Ingredient (2015-2020)
4.3 Global Codeine Price Market Share by Ingredient (2015-2020)
4.4 Global Codeine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Codeine Historic Market Analysis by Application
5.1 Global Codeine Sales Market Share by Application (2015-2020)
5.2 Global Codeine Revenue Market Share by Application (2015-2020)
5.3 Global Codeine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Codeine Business
6.1 Taiji
6.1.1 Corporation Information
6.1.2 Taiji Description, Business Overview and Total Revenue
6.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Taiji Products Offered
6.1.5 Taiji Recent Development
6.2 Mallinckrodt
6.2.1 Mallinckrodt Codeine Production Sites and Area Served
6.2.2 Mallinckrodt Description, Business Overview and Total Revenue
6.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Mallinckrodt Products Offered
6.2.5 Mallinckrodt Recent Development
6.3 TEVA
6.3.1 TEVA Codeine Production Sites and Area Served
6.3.2 TEVA Description, Business Overview and Total Revenue
6.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 TEVA Products Offered
6.3.5 TEVA Recent Development
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Codeine Production Sites and Area Served
6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Johnson & Johnson Products Offered
6.4.5 Johnson & Johnson Recent Development
6.5 Medreich
6.5.1 Medreich Codeine Production Sites and Area Served
6.5.2 Medreich Description, Business Overview and Total Revenue
6.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Medreich Products Offered
6.5.5 Medreich Recent Development
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Codeine Production Sites and Area Served
6.6.2 Sanofi Aventis Description, Business Overview and Total Revenue
6.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sanofi Aventis Products Offered
6.6.5 Sanofi Aventis Recent Development
6.7 Cipla
6.6.1 Cipla Codeine Production Sites and Area Served
6.6.2 Cipla Description, Business Overview and Total Revenue
6.6.3 Cipla Codeine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cipla Products Offered
6.7.5 Cipla Recent Development
6.8 Hikma
6.8.1 Hikma Codeine Production Sites and Area Served
6.8.2 Hikma Description, Business Overview and Total Revenue
6.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hikma Products Offered
6.8.5 Hikma Recent Development
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Codeine Production Sites and Area Served
6.9.2 Pharmaceutical Associates Description, Business Overview and Total Revenue
6.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Pharmaceutical Associates Products Offered
6.9.5 Pharmaceutical Associates Recent Development
6.10 Novartis
6.10.1 Novartis Codeine Production Sites and Area Served
6.10.2 Novartis Description, Business Overview and Total Revenue
6.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Novartis Products Offered
6.10.5 Novartis Recent Development
6.11 Apotex
6.11.1 Apotex Codeine Production Sites and Area Served
6.11.2 Apotex Codeine Description, Business Overview and Total Revenue
6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Apotex Products Offered
6.11.5 Apotex Recent Development
6.12 Mylan
6.12.1 Mylan Codeine Production Sites and Area Served
6.12.2 Mylan Codeine Description, Business Overview and Total Revenue
6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Mylan Products Offered
6.12.5 Mylan Recent Development
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Codeine Production Sites and Area Served
6.13.2 Aristo Pharma GmbH Codeine Description, Business Overview and Total Revenue
6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Aristo Pharma GmbH Products Offered
6.13.5 Aristo Pharma GmbH Recent Development
6.14 Lannett Company
6.14.1 Lannett Company Codeine Production Sites and Area Served
6.14.2 Lannett Company Codeine Description, Business Overview and Total Revenue
6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Lannett Company Products Offered
6.14.5 Lannett Company Recent Development
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Codeine Production Sites and Area Served
6.15.2 Laboratoire Riva Codeine Description, Business Overview and Total Revenue
6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Laboratoire Riva Products Offered
6.15.5 Laboratoire Riva Recent Development
7 Codeine Manufacturing Cost Analysis
7.1 Codeine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Codeine
7.4 Codeine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Codeine Distributors List
8.3 Codeine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Codeine Market Estimates and Projections by Ingredient
10.1.1 Global Forecasted Sales of Codeine by Ingredient (2021-2026)
10.1.2 Global Forecasted Revenue of Codeine by Ingredient (2021-2026)
10.2 Codeine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Codeine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Codeine by Application (2021-2026)
10.3 Codeine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Codeine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Codeine by Region (2021-2026)
10.4 North America Codeine Estimates and Projections (2021-2026)
10.5 Europe Codeine Estimates and Projections (2021-2026)
10.6 Asia Pacific Codeine Estimates and Projections (2021-2026)
10.7 Latin America Codeine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Codeine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Codeine Sales (M Units) Growth Rate Comparison by Ingredient (2015-2026)
Table 2. Global Codeine Sales (M Units) Comparison by Application: 2020 VS 2026
Table 3. Global Codeine Market Size by Ingredient (M Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Codeine Manufacturers Covered in This Study
Table 5. Global Codeine Sales (M Units) by Manufacturers (2015-2020)
Table 6. Global Codeine Sales Share by Manufacturers (2015-2020)
Table 7. Global Codeine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Codeine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Codeine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Codeine Sales Sites and Area Served
Table 11. Manufacturers Codeine Product Types
Table 12. Global Codeine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Codeine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Codeine Players
Table 16. Global Codeine Sales (M Units) by Region (2015-2020)
Table 17. Global Codeine Sales Market Share by Region (2015-2020)
Table 18. Global Codeine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Codeine Revenue Market Share by Region (2015-2020)
Table 20. North America Codeine Sales by Country (2015-2020) (M Units)
Table 21. North America Codeine Sales Market Share by Country (2015-2020)
Table 22. North America Codeine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Codeine Revenue Market Share by Country (2015-2020)
Table 24. Europe Codeine Sales by Country (2015-2020) (M Units)
Table 25. Europe Codeine Sales Market Share by Country (2015-2020)
Table 26. Europe Codeine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Codeine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Codeine Sales by Region (2015-2020) (M Units)
Table 29. Asia Pacific Codeine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Codeine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Codeine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Codeine Sales by Country (2015-2020) (M Units)
Table 33. Latin America Codeine Sales Market Share by Country (2015-2020)
Table 34. Latin America Codeine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Codeine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Codeine Sales by Country (2015-2020) (M Units)
Table 37. Middle East and Africa Codeine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Codeine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Codeine Revenue Market Share by Country (2015-2020)
Table 40. Global Codeine Sales (M Units) by Ingredient (2015-2020)
Table 41. Global Codeine Sales Share by Ingredient (2015-2020)
Table 42. Global Codeine Revenue (Million US$) by Ingredient (2015-2020)
Table 43. Global Codeine Revenue Share by Ingredient (2015-2020)
Table 44. Global Codeine Price (USD/Unit) by Ingredient (2015-2020)
Table 45. Global Codeine Sales (M Units) by Application (2015-2020)
Table 46. Global Codeine Sales Market Share by Application (2015-2020)
Table 47. Global Codeine Sales Growth Rate by Application (2015-2020)
Table 48. Taiji Codeine Corporation Information
Table 49. Taiji Description and Business Overview
Table 50. Taiji Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Taiji Main Product
Table 52. Taiji Recent Development
Table 53. Mallinckrodt Codeine Corporation Information
Table 54. Mallinckrodt Corporation Information
Table 55. Mallinckrodt Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Mallinckrodt Main Product
Table 57. Mallinckrodt Recent Development
Table 58. TEVA Codeine Corporation Information
Table 59. TEVA Corporation Information
Table 60. TEVA Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. TEVA Main Product
Table 62. TEVA Recent Development
Table 63. Johnson & Johnson Codeine Corporation Information
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Johnson & Johnson Main Product
Table 67. Johnson & Johnson Recent Development
Table 68. Medreich Codeine Corporation Information
Table 69. Medreich Corporation Information
Table 70. Medreich Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Medreich Main Product
Table 72. Medreich Recent Development
Table 73. Sanofi Aventis Codeine Corporation Information
Table 74. Sanofi Aventis Corporation Information
Table 75. Sanofi Aventis Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sanofi Aventis Main Product
Table 77. Sanofi Aventis Recent Development
Table 78. Cipla Codeine Corporation Information
Table 79. Cipla Corporation Information
Table 80. Cipla Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Cipla Main Product
Table 82. Cipla Recent Development
Table 83. Hikma Codeine Corporation Information
Table 84. Hikma Corporation Information
Table 85. Hikma Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Hikma Main Product
Table 87. Hikma Recent Development
Table 88. Pharmaceutical Associates Codeine Corporation Information
Table 89. Pharmaceutical Associates Corporation Information
Table 90. Pharmaceutical Associates Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Pharmaceutical Associates Main Product
Table 92. Pharmaceutical Associates Recent Development
Table 93. Novartis Codeine Corporation Information
Table 94. Novartis Corporation Information
Table 95. Novartis Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Novartis Main Product
Table 97. Novartis Recent Development
Table 98. Apotex Codeine Corporation Information
Table 99. Apotex Corporation Information
Table 100. Apotex Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Apotex Main Product
Table 102. Apotex Recent Development
Table 103. Mylan Codeine Corporation Information
Table 104. Mylan Corporation Information
Table 105. Mylan Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Mylan Main Product
Table 107. Mylan Recent Development
Table 108. Aristo Pharma GmbH Codeine Corporation Information
Table 109. Aristo Pharma GmbH Corporation Information
Table 110. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Aristo Pharma GmbH Main Product
Table 112. Aristo Pharma GmbH Recent Development
Table 113. Lannett Company Codeine Corporation Information
Table 114. Lannett Company Corporation Information
Table 115. Lannett Company Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Lannett Company Main Product
Table 117. Lannett Company Recent Development
Table 118. Laboratoire Riva Codeine Corporation Information
Table 119. Laboratoire Riva Corporation Information
Table 120. Laboratoire Riva Codeine Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Laboratoire Riva Main Product
Table 122. Laboratoire Riva Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Codeine Distributors List
Table 126. Codeine Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Codeine Sales (M Units) Forecast by Ingredient (2021-2026)
Table 131. Global Codeine Sales Market Share Forecast by Ingredient (2021-2026)
Table 132. Global Codeine Revenue (Million US$) Forecast by Ingredient (2021-2026)
Table 133. Global Codeine Revenue (Million US$) Market Share Forecast by Ingredient (2021-2026)
Table 134. Global Codeine Sales (M Units) Forecast by Application (2021-2026)
Table 135. Global Codeine Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Codeine Sales (M Units) Forecast by Region (2021-2026)
Table 137. Global Codeine Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Codeine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Codeine Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Codeine
Figure 2. Global Codeine Sales Market Share by Ingredient: 2020 VS 2026
Figure 3. Single-ingredient Codeine Product Picture
Figure 4. Multi-ingredient Medications Product Picture
Figure 5. Global Codeine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Narcotic Analgesic
Figure 7. Antitussive
Figure 8. Others
Figure 9. Global Codeine Market Size 2015-2026 (US$ Million)
Figure 10. Global Codeine Sales Capacity (M Units) (2015-2026)
Figure 11. Global Codeine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Codeine Sales Share by Manufacturers in 2020
Figure 13. Global Codeine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Codeine Revenue in 2019
Figure 15. Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Codeine Sales Market Share by Region (2015-2020)
Figure 17. Global Codeine Sales Market Share by Region in 2019
Figure 18. Global Codeine Revenue Market Share by Region (2015-2020)
Figure 19. Global Codeine Revenue Market Share by Region in 2019
Figure 20. North America Codeine Sales Market Share by Country in 2019
Figure 21. North America Codeine Revenue Market Share by Country in 2019
Figure 22. U.S. Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 23. U.S. Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 25. Canada Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Codeine Sales Market Share by Country in 2019
Figure 27. Europe Codeine Revenue Market Share by Country in 2019
Figure 28. Germany Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 29. Germany Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 31. France Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 33. U.K. Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 35. Italy Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 37. Russia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Codeine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Codeine Revenue Market Share by Region in 2019
Figure 40. China Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 41. China Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 43. Japan Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 45. South Korea Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 47. India Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 49. Australia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 51. Taiwan Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 53. Indonesia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 55. Thailand Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 57. Malaysia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 59. Philippines Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 61. Vietnam Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Codeine Sales Market Share by Country in 2019
Figure 63. Latin America Codeine Revenue Market Share by Country in 2019
Figure 64. Mexico Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 65. Mexico Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 67. Brazil Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 69. Argentina Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Codeine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Codeine Revenue Market Share by Country in 2019
Figure 72. Turkey Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 73. Turkey Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 75. Saudi Arabia Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Codeine Sales Growth Rate (2015-2020) (M Units)
Figure 77. U.A.E Codeine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Codeine by Ingredient (2015-2020)
Figure 79. Sales Market Share of Codeine by Ingredient in 2019
Figure 80. Revenue Share of Codeine by Ingredient (2015-2020)
Figure 81. Revenue Market Share of Codeine by Ingredient in 2019
Figure 82. Global Codeine Sales Growth by Ingredient (2015-2020) (M Units)
Figure 83. Global Codeine Sales Market Share by Application (2015-2020)
Figure 84. Global Codeine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Codeine by Application (2015-2020)
Figure 86. Global Revenue Share of Codeine by Application in 2020
Figure 87. Taiji Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Medreich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Pharmaceutical Associates Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Aristo Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Lannett Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Laboratoire Riva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Codeine
Figure 104. Manufacturing Process Analysis of Codeine
Figure 105. Codeine Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Codeine Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 110. North America Codeine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Codeine Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Codeine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Codeine Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Codeine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Codeine Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Codeine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Codeine Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Codeine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs